These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11583747)

  • 81. Myocardial revascularisation: the search for the holy grail.
    Coats AJ
    Int J Cardiol; 2000 Mar; 73(1):1-2. PubMed ID: 10748302
    [No Abstract]   [Full Text] [Related]  

  • 82. Approach to symptomatic coronary disease in the elderly: TIME to change?
    Aronow WS
    Lancet; 2001 Sep; 358(9286):945-6. PubMed ID: 11583742
    [No Abstract]   [Full Text] [Related]  

  • 83. Coronary Artery Disease in Chronic Kidney Disease: Need for a Heart-Kidney Team-Based Approach.
    Shroff GR; Carlson MD; Mathew RO
    Eur Cardiol; 2021 Feb; 16():e48. PubMed ID: 34950244
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Impact of revascularisation on outcomes in chronic coronary syndromes: a new meta-analysis with the same old biases?
    Brown DL; Boden WE
    Eur Heart J; 2021 Dec; 42(45):4652-4655. PubMed ID: 34110408
    [No Abstract]   [Full Text] [Related]  

  • 85. [Surgical treatment of coronary heart disease in elderly patients].
    Borisov IA; Rudakov AS; Bletkin AN; Uĭmanova MIu; Novosel'tsev OS; Dalinin VV; Dulin AP
    Klin Med (Mosk); 2013; 91(2):52-7. PubMed ID: 23718067
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [There is bank and data bank].
    Junod AF
    Rev Med Suisse; 2009 Mar; 5(196):693. PubMed ID: 19462614
    [No Abstract]   [Full Text] [Related]  

  • 87. Trends in cardiac medicine: the American Heart Association meeting, New Orleans, November 16-19, 1992.
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):283-5. PubMed ID: 8357783
    [No Abstract]   [Full Text] [Related]  

  • 88. Cardiac mortality, adequate power, and objective inclusion of the entire evidence are key to accurately define the long-term effect of revascularisation vs. medical therapy alone in stable coronary syndromes.
    Navarese EP; Andreotti F
    Eur Heart J; 2021 Dec; 42(45):4699-4700. PubMed ID: 34545407
    [No Abstract]   [Full Text] [Related]  

  • 89. [Medical treatment of coronary artery disease].
    Proulx A
    Union Med Can; 1957 Sep; 86(9):954-60. PubMed ID: 13468179
    [No Abstract]   [Full Text] [Related]  

  • 90. The ISCHEMIA Trial: What is the Message for the Interventionalist?
    Ako E; Nijjer S; Al-Hussaini A; Kaprielian R
    Eur Cardiol; 2021 Feb; 16():e24. PubMed ID: 34135994
    [No Abstract]   [Full Text] [Related]  

  • 91. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.
    Davies RF; Goldberg AD; Forman S; Pepine CJ; Knatterud GL; Geller N; Sopko G; Pratt C; Deanfield J; Conti CR
    Circulation; 1997 Apr; 95(8):2037-43. PubMed ID: 9133513
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
    Lamy A; Devereaux PJ; Prabhakaran D; Taggart DP; Hu S; Straka Z; Piegas LS; Avezum A; Akar AR; Lanas Zanetti F; Jain AR; Noiseux N; Padmanabhan C; Bahamondes JC; Novick RJ; Tao L; Olavegogeascoechea PA; Airan B; Sulling TA; Whitlock RP; Ou Y; Gao P; Pettit S; Yusuf S;
    N Engl J Med; 2016 Dec; 375(24):2359-2368. PubMed ID: 27771985
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants.
    Lancet; 1997 Aug; 350(9076):461-8. PubMed ID: 9274581
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.
    Windecker S; Stortecky S; Stefanini GG; da Costa BR; Rutjes AW; Di Nisio M; Silletta MG; Maione A; Alfonso F; Clemmensen PM; Collet JP; Cremer J; Falk V; Filippatos G; Hamm C; Head S; Kappetein AP; Kastrati A; Knuuti J; Landmesser U; Laufer G; Neumann FJ; Richter D; Schauerte P; Sousa Uva M; Taggart DP; Torracca L; Valgimigli M; Wijns W; Witkowski A; Kolh P; Jüni P
    BMJ; 2014 Jun; 348():g3859. PubMed ID: 24958153
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Optimal medical therapy with or without PCI for stable coronary disease.
    Boden WE; O'Rourke RA; Teo KK; Hartigan PM; Maron DJ; Kostuk WJ; Knudtson M; Dada M; Casperson P; Harris CL; Chaitman BR; Shaw L; Gosselin G; Nawaz S; Title LM; Gau G; Blaustein AS; Booth DC; Bates ER; Spertus JA; Berman DS; Mancini GB; Weintraub WS;
    N Engl J Med; 2007 Apr; 356(15):1503-16. PubMed ID: 17387127
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial.
    Erne P; Schoenenberger AW; Burckhardt D; Zuber M; Kiowski W; Buser PT; Dubach P; Resink TJ; Pfisterer M
    JAMA; 2007 May; 297(18):1985-91. PubMed ID: 17488963
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Coronary-artery bypass surgery in patients with left ventricular dysfunction.
    Velazquez EJ; Lee KL; Deja MA; Jain A; Sopko G; Marchenko A; Ali IS; Pohost G; Gradinac S; Abraham WT; Yii M; Prabhakaran D; Szwed H; Ferrazzi P; Petrie MC; O'Connor CM; Panchavinnin P; She L; Bonow RO; Rankin GR; Jones RH; Rouleau JL;
    N Engl J Med; 2011 Apr; 364(17):1607-16. PubMed ID: 21463150
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.
    Mohr FW; Morice MC; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Morel MA; Van Dyck N; Houle VM; Dawkins KD; Serruys PW
    Lancet; 2013 Feb; 381(9867):629-38. PubMed ID: 23439102
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results.
    Hueb W; Soares PR; Gersh BJ; César LA; Luz PL; Puig LB; Martinez EM; Oliveira SA; Ramires JA
    J Am Coll Cardiol; 2004 May; 43(10):1743-51. PubMed ID: 15145093
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial.
    Pfisterer M; Buser P; Osswald S; Allemann U; Amann W; Angehrn W; Eeckhout E; Erne P; Estlinbaum W; Kuster G; Moccetti T; Naegeli B; Rickenbacher P;
    JAMA; 2003 Mar; 289(9):1117-23. PubMed ID: 12622581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.